Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_999_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
330
https://t.me/med1917
ndings highlighted the advantages of delayed renal replacement therapy in criti­cally ill patients [60], which does not promote early initiation of renal replace­ment therapy for uid removal. In continuous renal replacement therapy, a net ultraltration between 1 and 1.75mL/kg/h is associated with a better prognosis [33]. Targeting a net ultraltration of 2mL/kg/h provides a signicant decrease in uid balance (if uid intake is restrictive) and seems safe, provided a strict hemo­dynamic monitoring [38]. In chronic intermittent hemodialysis, a net ultraltra­tion over 10mL/kg/h is associated with increased mortality [61]; hence, it seems reasonable to use lower net ultraltration rate in critically ill patients. To this purpose, prolonged, more frequent sessions or isolated ultraltration may be car­ried out to induce a negative uid balance [62]. Regarding the control of uid balance, experts have suggested to not wean renal replacement if the diuresis is lower than 2L/day with diuretics [63]. To nish, recent data indicates to avoid transition from continuous renal replacement therapy to intermittent hemodialy­sis if uid accumulation persists, as it has shown as a marker of poor hemody­namic tolerance of intermittent hemodialysis [64].
M. Ruste et al.
Deresuscitation: Do Not Forget Fluid Intake
If restrictive strategies to initial resuscitation is beyond the scope of this focus, a tight control of uid intake remains an integral part of deresuscitation strategy. A recent cohort emphasized that, in real-life, resuscitation uids only count for 6.6% of the uid intake during the ICU stay, whereas maintenance uids count for 25%, nutrition for 33% and uid creep (uids administrated as a vehicle for medication or electrolytes) for 33%. Besides, resuscitation uids’ contribution to uid balance decreases throughout the ICU stay, and the major determinants of the positive cumulative uid balance, sodium and chloride burden are uids of maintenance and uid creep [20]. In this regard, the prescription of maintenance uids and dilution for medication needs special attention as they largely participate to sodium and chloride load. As sodium-induced uid retention and chloride-related renal vaso­constriction could be responsible for uid accumulation themselves, maintenance uids should preferably be orally administrated, hypotonic and for a total amount of intake without exceeding 25–30mL/kg/day and 1mmol/kg/day of sodium [65]. To
20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
331
this purpose, dissolving as many medications as possible in glucose 5% is efcient and probably safe [66].
Suggestions for daily clinical practice concerning deresuscitation are provided in Figs.20.2 and 20.3.
Fig. 20.2 Deresuscitation and monitoring
332
https://t.me/med1917
M. Ruste et al.
Fig. 20.3 Deresuscitation: suggestions for clinical practice. RRT Renal replacement therapy
20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
333
Deresuscitation: Evidence-Based Patient-Centered Impact
If uid overload was constantly associated with a worse prognosis, the causality link is not well-established. Thus, as a patient–physician interaction, uid accumu­lation is probably in part inherent to pathological patient-related factors as capillary leakage and organ failure, which obviously participate in this worse prognosis. In this regard, interventional studies aiming to decrease uid overload have shown relatively disappointing results. If restrictive strategies may help the mechanical ventilation weaning without improving mortality [67, 68], high-quality trials are scarce on deresuscitation strategy itself. They have shown difculties to elaborate allowing a signicant decrease in cumulative uid balance and did not show any signicant improvement in patients with sepsis outcomes [69]. A recent large ran­domized trial illustrates those difculties: a protocol targeting a progressive weight decrease after day 2, using albumin, diuretics or ultraltration failed to decrease cumulative uid balance compared to usual care [70]. Despite a complex dedicated design, the trial suffered from contamination between groups. Suboptimal protocol adherence was also reported and the strict safety criteria (suspension of the deresus­citation strategy if arterial hypotension, vasopressor requirement, renal function deterioration) may have induced undertreatment in the interventional group. However, to decrease cumulative uid balance with deresuscitation strategy is not a quixotic goal as shown by two recent interventional or quasi-experimental studies [38, 71]. It must be noted that besides acute kidney injury and restrictive strategies in the peri-operative setting [72, 73] or cognitive dysfunction and restrictive strategy in acute respiratory distress syndrome [74], no sign of harm were suggested by stud­ies on deresuscitation. It has to be modulated by the fact that data are scarce and originate from deresuscitation protocols with restrictive safety criteria applied to stabilized patients.
To conclude, if several experts support the concept of deresuscitation or de­escalation [40, 75], the lack of solid evidence-based demonstration of its clinical interest highlights the gap between physician practices and scientic knowledge. It may explain the heterogeneity in diagnosis and therapeutic interventions observed worldwide in several surveys on uid overload and uid removal [19, 7678]. In this context, trials are urgently needed to determine the eligible population, the safety criteria, the targets and the means to “deresuscitate.”
Acknowledgment Authors thank Lucie Bernigaud for help in manuscript preparation.
Conict of Interest Statement The authors have no conicts of interest related to the manuscript
to declare.
Funding Sources
Author Contributions Drafting of manuscript: MR.
Critical revision of the manuscript for important intellectual content: MR, MJL, JLF.
No funding source.
334
https://t.me/med1917
M. Ruste et al.
References
1. Messmer AS, Zingg C, Müller M, Gerber JL, Schefold JC, Pfortmueller CA.Fluid overload and mortality in adult critical care patients—a systematic review and meta-analysis of obser­vational studies*. Crit Care Med. 2020;48(12):1862–70.
2. Zhang L, Chen Z, Diao Y, Yang Y, Fu P. Associations of uid overload with mortality and kidney recovery in patients with acute kidney injury: a systematic review and meta-analysis. J Crit Care. 2015;30(4):860.e7–13.
3. Woodward CW, Lambert J, Ortiz-Soriano V, Li Y, Ruiz-Conejo M, Bissell BD, et al. Fluid overload associates with Major adverse kidney events in critically ill patients with acute kidney injury requiring continuous renal replacement therapy. Crit Care Med. 2019;47(9):e753–60.
4. Mele A, Cerminara E, Häbel H, Rodriguez-Galvez B, Oldner A, Nelson D, etal. Fluid accu­mulation and major adverse kidney events in sepsis: a multicenter observational study. Ann Intensive Care. 2022;12(1):62.
5. Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, etal. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care Lond Engl. 2016;20(1):196.
6. Schneider AG, Thorpe C, Dellbridge K, Matalanis G, Bellomo R.Electronic bed weighing vs daily uid balance changes after cardiac surgery. J Crit Care. 2013;28(6):1113.e1–5.
7. Perren A, Markmann M, Merlani G, Marone C, Merlani P. Fluid balance in critically ill patients. Should we really rely on it? Minerva Anestesiol. 2011;77(8):802–11.
8. Davies H, Leslie G, Jacob E, Morgan D.Estimation of body uid status by uid balance and body weight in critically ill adult patients: a systematic review. Worldviews Evid Based Nurs. 2019;16(6):470–7.
9. Vincent JL, Pinsky MR.We should avoid the term « uid overload ». Crit Care Lond Engl. 2018;22(1):214.
10. Malbrain MLNG, Martin G, Ostermann M.Everything you need to know about deresuscita­tion. Intensive Care Med. 2022;48:1781.
11. Vincent JL, De Backer D.Circulatory shock. N Engl J Med. 2013;369(18):1726–34.
12. O’Connor ME, Prowle JR.Fluid overload. Crit Care Clin. 2015;31(4):803–21.
13. Hahn RG.Understanding volume kinetics. Acta Anaesthesiol Scand. 2020;64(5):570–8.
14. Tatara T.Context-sensitive uid therapy in critical illness. J Intensive Care. 2016;4(1):20.
15. Collins SR, Blank RS, Deatherage LS, Dull RO.The endothelial glycocalyx: emerging con­cepts in pulmonary edema and acute lung injury. Anesth Analg. 2013;117(3):664–74.
16. Lee WL, Slutsky AS.Sepsis and endothelial permeability. N Engl J Med. 2010;363(7):689–91.
17. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6(2):107–15.
18. Malbrain MLNG, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, etal. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361–80.
19. Silversides JA, McAuley DF, Blackwood B, Fan E, Ferguson AJ, Marshall JC.Fluid manage­ment and deresuscitation practices: a survey of critical care physicians. J Intensive Care Soc. 2020;21(2):111–8.
20. Van Regenmortel N, Verbrugghe W, Roelant E, Van den Wyngaert T, Jorens PG.Maintenance uid therapy and uid creep impose more signicant uid, sodium, and chloride burdens than resuscitation uids in critically ill patients: a retrospective study in a tertiary mixed ICU popu­lation. Intensive Care Med. 2018;44(4):409–17.
21. For the ICON Investigators, Vincent JL, Ferguson A, Pickkers P, Jakob SM, Jaschinski U, etal. The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database. Crit Care. 2020;24(1):171.
22. Sanlippo F, Corredor C, Fletcher N, Landesberg G, Benedetto U, Foex P, et al. Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. Intensive Care Med. 2015;41(6):1004–13.
20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
23. Dugar S, Sato R, Chawla S, You JY, Wang X, Grimm R, etal. Is left ventricular systolic dys­function associated with increased mortality among patients with sepsis and septic shock? Chest. 2023:S0012369223001113.
24. Ruiz P, de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M.Critical care hepatology: denitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care. 2022;26(1):289.
25. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, etal. The endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007;73(3):575–86.
26. Prowle J, Mehta R.Fluid balance management during continuous renal replacement therapy. Semin Dial. 2021;34(6):440–8.
27. Oh TK, Song IA, Do SH, Jheon S, Lim C.Association of perioperative weight-based uid balance with 30-day mortality and acute kidney injury among patients in the surgical intensive care unit. J Anesth. 2019;33(3):354–63.
28. Wollborn J, Hassenzahl LO, Reker D, Staehle HF, Omlor AM, Baar W, et al. Diagnosing capillary leak in critically ill patients: development of an innovative scoring instrument for non-invasive detection. Ann Intensive Care. 2021;11(1):175.
29. Stein A, de Souza LV, Belettini CR, Menegazzo WR, Viégas JR, Costa Pereira EM, etal. Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort study. Crit Care Lond Engl. 2012;16(3):R99.
30. Shen Y, Zhang W, Cheng X, Ying M.Association between postoperative uid balance and acute kidney injury in patients after cardiac surgery: a retrospective cohort study. J Crit Care. 2018;44:273–7.
31. Miller TE, Mythen M, Shaw AD, Hwang S, Shenoy AV, Bershad M, etal. Association between perioperative uid management and patient outcomes: a multicentre retrospective study. Br J Anaesth. 2021;126(3):720–9.
32. Silva JM, de Oliveira AMRR, Nogueira FAM, Vianna PMM, Pereira Filho MC, Dias LF, etal. The effect of excess uid balance on the mortality rate of surgical patients: a multicenter pro­spective study. Crit Care Lond Engl. 2013;17(6):R288.
33. Murugan R, Bellomo R, Palevsky P, Kellum JA.Ultraltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol. 2020;17:262.
34. Marik PE.Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care. 2014;4(1):21.
35. Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, etal. The passive leg raising test to guide uid removal in critically ill patients. Ann Intensive Care [Internet]. 2016;6(1):46. [cité 10 oct 2018] Disponible sur: http://annalsontensivecare.springeropen.
com/articles/10.1186/s13613- 016- 0149- 1
36. Klijn E, Groeneveld ABJ, van Genderen ME, Betjes M, Bakker J, van Bommel J.Peripheral perfusion index predicts hypotension during uid withdrawal by continuous Veno-venous hemoltration in critically ill patients. Blood Purif. 2015;40(1):92–8.
37. Legrand M, Soussi S, Depret F.Cardiac output and CVP monitoring… to guide uid removal. Crit Care Lond Engl. 2018;22(1):89.
38. Ruste M, Sghaier R, Chesnel D, Didier L, Fellahi JL, Jacquet-Lagrèze M.Perfusion-based deresuscitation during continuous renal replacement therapy: a before-after pilot study (the early dry cohort). J Crit Care. 2022;72:154169.
39. Rosner MH, Ostermann M, Murugan R, Prowle JR, Ronco C, Kellum JA, etal. Indications and management of mechanical uid removal in critical illness. Br J Anaesth. 2014;113(5):764–71.
40. De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tascón GA, etal. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022;26(1):372.
41. Samoni S, Vigo V, Bonilla Reséndiz LI, Villa G, De Rosa S, Nalesso F, etal. Impact of hyper­hydration on the mortality risk in critically ill patients admitted in intensive care units: compar­ison between bioelectrical impedance vector analysis and cumulative uid balance recording. Crit Care. 2016;20(1):95.
335
336
https://t.me/med1917
42. Rhee H, Jang KS, Shin MJ, Lee JW, Kim IY, Song SH, etal. Use of multifrequency bioimped­ance analysis in male patients with acute kidney injury who are undergoing continuous Veno­venous Hemodialtration. PLoS One. 2015;10(7):e0133199.
43. Moonen HPFX, Van Zanten ARH. Bioelectric impedance analysis for body composition measurement and other potential clinical applications in critical illness. Curr Opin Crit Care. 2021;27(4):344–53.
44. Cleymaet R, Scheinok T, Maes H, Stas A, Malbrain L, De Laet I, etal. Prognostic value of bioelectrical impedance analysis for assessment of uid overload in ICU patients: a pilot study. Anaesthesiol Intensive Ther. 2021;53(1):10–7.
45. Madsen JM, Wichmann S, Bestle MH, Itenov TS.Bioimpedance as a measure of uid status in critically ill patients: a systematic review. Acta Anaesthesiol Scand. 2021;65(9):1155–67.
46. De Laet I, Deeren D, Schoonheydt K, Van Regenmortel N, Dits H, Malbrain ML. Renal replacement therapy with net uid removal lowers intra-abdominal pressure and volumetric indices in critically ill patients. Ann Intensive Care. 2012;2(Suppl 1):S20.
47. Goudelin M, Champy P, Amiel JB, Evrard B, Fedou AL, Daix T, etal. Left ventricular over­loading identied by critical care echocardiography is key in weaning-induced pulmonary edema. Intensive Care Med. 2020;46(7):1371–81.
48. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, etal. Comparison of two uid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75.
49. Wallbach M, Valentova M, Schroeter MR, Alkabariti A, Iraki I, Leha A, et al. Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure under­going recompensation. Clin Res Cardiol [Internet]. 2023; [cité 22 mai 2023]; Disponible sur:
https://link.springer.com/10.1007/s00392- 023- 02184- 6
50. Aronson D, Abassi Z, Allon E, Burger AJ.Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail. 2013;15(6):637–43.
51. Uz Z, Ince C, Guerci P, Ince Y, Araujo RP, Ergin B, etal. Recruitment of sublingual microcir­culation using handheld incident dark eld imaging as a routine measurement tool during the postoperative de-escalation phase—a pilot study in post ICU cardiac surgery patients. Perioper Med. 2018;7(1):18.
52. Deschamps J, Denault A, Galarza L, Rola P, Ledoux-Hutchinson L, Huard K, etal. Venous Doppler to assess congestion: a comprehensive review of current evidence and nomenclature. Ultrasound Med Biol. 2023;49(1):3–17.
53. Guinot PG, Bahr PA, Andrei S, Popescu BA, Caruso V, Mertes PM, etal. Doppler study of portal vein and renal venous velocity predict the appropriate uid response to diuretic in ICU: a prospective observational echocardiographic evaluation. Crit Care. 2022;26(1):305.
54. McCoy IE, Chertow GM, Chang TIH.Patterns of diuretic use in the intensive care unit. PLoS One. 2019;14(5):e0217911.
55. Côté JM, Bouchard J, Murray PT, Beaubien-Souligny W.Diuretic strategies in patients with resistance to loop-diuretics in the intensive care unit: a retrospective study from the MIMIC-III database. J Crit Care. 2021;65:282–91.
56. Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, etal. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43(6):730–49.
57. Shahn Z, Lehman LWH, Mark RG, Talmor D, Bose S. Delaying initiation of diuretics in critically ill patients with recent vasopressor use and high positive uid balance. Br J Anaesth. 2021;127(4):569–76.
58. Douvris A, Zeid K, Hiremath S, Bagshaw SM, Wald R, Beaubien-Souligny W, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333–46.
59. Benichou N, Gaudry S, Dreyfuss D.The articial kidney induces acute kidney injury: yes. Intensive Care Med. 2020;46(3):513–5.
60. Gaudry S, Hajage D, Benichou N, Chaïbi K, Barbar S, Zarbock A, et al. Delayed ver­sus early initiation of renal replacement therapy for severe acute kidney injury: a system-
M. Ruste et al.
20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
atic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020;395(10235):1506–15.
61. Assimon MM, Wenger JB, Wang L, Flythe JE.Ultraltration rate and mortality in mainte­nance hemodialysis patients. Am J Kidney Dis. 2016;68(6):911–22.
62. Gaudry S, Palevsky PM, Dreyfuss D.Extracorporeal kidney-replacement therapy for acute kidney injury. Ingelnger JR, éditeur. N Engl J Med. 2022;386(10):964–75.
63. Wald R, Beaubien-Souligny W, Chanchlani R, Clark EG, Neyra JA, Ostermann M, et al. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022;48(10):1368–81.
64. Beaubien-Souligny W, Yang Y, Burns KEA, Friedrich JO, Meraz-Muñoz A, Clark EG, etal. Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy. Ann Intensive Care. 2021;11(1):96.
65. Van Regenmortel N, Moers L, Langer T, Roelant E, De Weerdt T, Caironi P, et al. Fluid­induced harm in the hospital: look beyond volume and start considering sodium. From physi­ology towards recommendations for daily practice in hospitalized adults. Ann Intensive Care. 2021;11(1):79.
66. Bihari S, Prakash S, Potts S, Matheson E, Bersten AD.Addressing the inadvertent sodium and chloride burden in critically ill patients: a prospective before-and-after study in a ter­tiary mixed intensive care unit population. Crit Care Resusc J Australas Acad Crit Care Med. 2018;20(4):285–93.
67. Silversides JA, Major E, Ferguson AJ, Mann EE, McAuley DF, Marshall JC, etal. Conservative uid management or deresuscitation for patients with sepsis or acute respiratory distress syn­drome following the resuscitation phase of critical illness: a systematic review and meta­analysis. Intensive Care Med. 2017;43(2):155–70.
68. Reynolds PM, Stefanos S, MacLaren R.Restrictive resuscitation in patients with sepsis and mortality: a systematic review and - with trial sequential analysis. Pharmacother J Hum Pharmacol Drug Ther. 2023;43(2):104–14.
69. Messmer AS, Dill T, Müller M, Pfortmueller CA.Active uid de-resuscitation in critically ill patients with septic shock: a systematic review and meta-analysis. Eur J Intern Med. 2023;109:89–96.
70. Bollaert PE, Monnier A, Schneider F, Argaud L, Badie J, Charpentier C, etal. Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trial. Crit Care. 2023;27(1):66.
71. Silversides JA, McMullan R, Emerson LM, Bradbury I, Bannard-Smith J, Szakmany T, etal. Feasibility of conservative uid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) ran­domised clinical trial. Intensive Care Med. 2022;48(2):190–200.
72. Chiu C, Fong N, Lazzareschi D, Mavrothalassitis O, Kothari R, Chen LL, etal. Fluids, vaso­pressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth. 2022;129(3):317–26.
73. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, etal. Restrictive versus liberal uid therapy for major abdominal surgery. N Engl J Med. 2018;378(24):2263–74.
74. Mikkelsen ME, Christie JD, Lanken PN, Biester RC, Thompson BT, Bellamy SL, etal. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med. 2012;185(12):1307–15.
75. Malbrain MLNG, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, etal. Intravenous uid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020;10(1):64.
76. Murugan R, Ostermann M, Peng Z, Kitamura K, Fujitani S, Romagnoli S, etal. Net ultraltra­tion prescription and practice among critically ill patients receiving renal replacement therapy: a multinational survey of critical care practitioners. Crit Care Med. 2020;48(2):e87–97.
77. Lumlertgul N, Murugan R, Seylanova N, McCready P, Ostermann M.Net ultraltration pre­scription survey in Europe. BMC Nephrol. 2020;21(1):522.
78. Zeuthen E, Wichmann S, Schønemann-Lund M, Järvisalo MJ, Rubenson-Wahlin R, Sigurðsson MI, etal. Nordic survey on assessment and treatment of uid overload in intensive care. Front Med. 2022;9:1067162.
337
Chapter 21
https://t.me/med1917
Extracorporeal Membrane Oxygenation
SasaRajsic, BenediktTreml, andRobertBreitkopf
Introduction
Extracorporeal membrane oxygenation (ECMO, extracorporeal life support [ECLS]) presents a temporary life-saving technology used in patients with refrac­tory cardiogenic shock or severe pulmonary failure. The main aim of ECMO is providing cardiac or respiratory support until the patient’s heart or lungs recover. Moreover, it can bridge the time to organ transplantation or permanent organ assis­tance, such as mechanical circulatory support devices, ventricular assist devices, or total articial heart.
The rst reports on the use of a prolonged extracorporeal circuit and the begin­ning of ECMO support date from 1972 (Bramson-membrane heart-lung machine) [1]. Over the last two decades, the use of ECMO has expanded beyond severe car­diorespiratory failure, comprising an assortment of clinical presentations. Refractory cardiac arrest requiring prolonged resuscitation (i.e., refractory ventricular arrhyth­mias, local anesthetics intoxication, etc.) is an evolving indication for extracorpo­real cardiopulmonary reanimation (eCPR). The successful use of ECMO support for out-of-hospital cardiac arrest is gaining popularity [25]. Moreover, ECMO sup­port is increasingly used as bridge to heart and/or lung transplantation, rewarming of patients with deep hypothermia, or treating hypoxic respiratory failure triggered by trauma [610] or COVID-19 [11].
However, the overall survival after ECMO depends on many intrinsic variables of the patient, besides the interactions between extracorporeal circulation, circuit
S. Rajsic (*) · B. Treml · R. Breitkopf Medical University Innsbruck, Innsbruck, Austria e-mail: sasa.rajsic@i-med.ac.at; benedikt.treml@i-med.ac.at;
robert.breitkopf@tirol-kliniken.at
Switzerland AG 2024 J. Faintuch, S. Faintuch (eds.), Recent Strategies in High Risk Surgery,
https://doi.org/10.1007/978-3-031-56270-9_21
339© The Author(s), under exclusive license to Springer Nature
340
https://t.me/med1917
S. Rajsic et al.
surface, hemostatic factors and blood components; generating complex coagulation and inammatory reactions; and making the management of the critically ill more complex [12].
ECMO Physiology andCircuit
Homeostasis in critically ill patients, particularly those receiving ECMO support, is multifactorially compromised. Cardiac surgery or ECMO implantation (surgical trauma) and exposure of the patient’s blood to the large surface of the circuit initiate and propagate an immediate inammatory reaction and activation of the coagula­tion cascade [13]. Numerous cellular and humoral systems are involved in these complex inammatory responses during ECMO support, resulting in a procoagu­lant state of the organism and the need for systemic anticoagulation. The balance between procoagulant factors and the iatrogenic coagulopathy is crucial to avoid severe adverse events (both hemorrhagic and/or thromboembolic), and for the patency of the circuit and its components [13].
The ECMO circuit is a closed system with a membrane-type gas-exchange tech­nology. The main distinction between ECMO and a cardiopulmonary bypass is in the air–blood interface and the duration of support. In contrast to ECMO, venous reser­voirs are integrated into cardiopulmonary bypass circuits for cardiotomy suction and venting of blood. Moreover, while cardiopulmonary bypass is usually used only for the surgery duration, ECMO support may be employed for weeks or even months [14].
The ECMO circuit comprises of inow and outow cannulas, a pump, an oxy­genator, and heat exchanger (Fig.21.1). The system components are connected by
Fig. 21.1 Venovenous-ECMO circuit: cannulation of the internal jugular and femoral vein (Courtesy Getinge AB, Rastatt, Germany)